The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSNP.L Regulatory News (SNP)

  • There is currently no data for SNP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

INTENTION TO DELIST ADSs FROM THE NYSE

12 Aug 2022 10:23

RNS Number : 8686V
China Petroleum & Chemical Corp
12 August 2022
 

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

 

 

 

ANNOUNCEMENT OF INTENTION TO

DELIST AMERICAN DEPOSITARY SHARES FROM THE NEW YORK STOCK EXCHANGE

 

China Petroleum & Chemical Corporation (the "Company") has notified the New York Stock Exchange ("NYSE") on 12 August 2022 (Eastern Time in the U.S., the same hereinafter) that it will apply for the voluntary delisting of its American depositary shares ("ADSs") from the NYSE under the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act"). The board of directors of the Company approved the delisting of its ADSs from the NYSE as well as the application for the deregistration of such ADSs and the underlying H Shares, where such application is subject to the Company satisfying the relevant requirements of the Exchange Act and depends on the relevant actual circumstances in the future. The determination was based on several comprehensive considerations, including the small volume of the underlying H Shares of its outstanding ADSs compared to the total volume of its H Shares, the limited trading volume of its ADSs relative to the worldwide trading volume of its H Shares and the considerable administrative burden of maintaining the listing of the ADSs on the NYSE, the registration of the ADSs and the underlying H Shares with the United States Securities and Exchange Commission (the "SEC") and complying with the periodic reporting and related obligations of the Exchange Act in the long term.

 

The Company intends to file a Form 25 with the SEC on or about 29 August 2022 to de-list its ADSs from the NYSE. The delisting of the ADSs from the NYSE is expected to become effective ten days thereafter. From and after the effective date, the Company will no longer list its ADSs on the NYSE.

 

Once the delisting has become effective, depending on the relevant actual circumstances in the future, the Company may seek to deregister the Company's ADSs and the underlying H Shares under the Exchange Act and terminate the related disclosure obligations in accordance with the relevant regulatory requirements and procedures, provided that the relevant standards of the Exchange Act (such as those set forth in Rule 12h-6 under the Exchange Act) are met. The Company will also consider whether to terminate its ADS program in due course in accordance with the deposit agreement based on the relevant actual circumstances.

 

The Company reserves its rights in all respects to delay or withdraw the aforementioned filings prior

to their effectiveness and will disclose any further announcement if required under the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") or other applicable laws.

 

The Company will continue to comply with its disclosure obligations under the Listing Rules and maintain smooth communication with investors.

 

By order of the Board

China Petroleum & Chemical Corporation

Huang Wensheng

Vice President, Secretary to the Board of Directors

 

Beijing, the PRC12 August 2022

As of the date of this announcement, directors of the Company are: Ma Yongsheng*, Zhao Dong*, Yu Baocai#, Ling Yiqun#, Li Yonglin#, Liu Hongbin#, Cai Hongbin+, Ng, Kar Ling Johnny+, Shi Dan+ and Bi Mingjian+.

# Executive Director* Non-executive Director+ Independent Non-executive Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANPAFAFAEEA
12
Date   Source Headline
28th Oct 202210:14 amRNS3rd Quarter Results
3rd Oct 20227:00 amRNSStatement re Intention to Delist ADSs from the LSE
30th Aug 20227:00 amRNSHalf-year Report
12th Aug 202210:23 amRNSINTENTION TO DELIST ADSs FROM THE NYSE
27th Jun 20229:46 amRNSReport on Payments to Govts
27th Apr 20229:47 amRNS1st Quarter Results
28th Mar 20227:00 amRNSAnnual Financial Report-2
28th Mar 20227:00 amRNSAnnual Financial Report-1
27th Jan 20229:49 amRNSTrading Statement
28th Oct 202110:54 amRNS3rd Quarter Results
31st Aug 20217:00 amRNSHalf-year Report
1st Jul 202111:36 amRNSTrading Statement
16th Jun 20219:46 amRNSReport on Payments to Govts
25th May 202111:31 amRNSResult of AGM
28th Apr 20219:39 amRNS1st Quarter Results
29th Mar 20217:00 amRNSEstimated Increase in Profit for Q1 2021
29th Mar 20217:00 amRNSAnnual Financial Report-part 2
29th Mar 20217:00 amRNSAnnual Financial Report
28th Oct 20208:56 amRNS3rd Quarter Results
1st Sep 20207:00 amRNSHalf-year Report
28th May 20209:46 amRNSReport on Payments to Govts
29th Apr 202010:03 amRNS1st Quarter Results
23rd Apr 202012:38 pmRNSAnnual Financial Report - Part 2
23rd Apr 202012:37 pmRNSAnnual Financial Report - Part 1
30th Mar 20207:00 amRNSFinal Results - Part 2
30th Mar 20207:00 amRNSFinal Results - Part 1
10th Dec 20199:37 amRNSStatement re Restructuring Oil&Gas Pipeline Assets
30th Oct 20199:16 amRNS3rd Quarter Results
27th Aug 20197:00 amRNSHalf-year Report
31st May 20199:36 amRNSReport on Payments to Govts
29th Apr 201911:49 amRNS1st Quarter Results
25th Mar 20198:19 amRNSFinal Results - Part 2
25th Mar 20198:17 amRNSFinal Results - Part 1
25th Jan 20199:21 amRNSProgress Update Announcement
25th Jan 20199:11 amRNSOperational Statistics for 2018
25th Jan 20199:07 amRNSAnnouncement on Preliminary Financial Data of 2018
4th Jan 201910:45 amRNSFurther re ANNOUNCEMENT UNUSUAL PRICE MOVEMENT
27th Dec 20182:19 pmRNSStmnt re Share Price Movement
30th Oct 201812:08 pmRNS3rd Quarter Results
16th Oct 201812:49 pmRNSEstimated Increase in Profit ended 30 Sep. 2018
28th Aug 20187:10 amRNSHalf-year Report
24th Jul 201810:13 amRNSEstimated Increase in Profit for the 1H 2018
13th Jun 201810:58 amRNSReport on Payments to Govts
15th May 20183:04 pmRNSResult of AGM
26th Apr 201811:31 amRNS1st Quarter Results
26th Mar 20187:23 amRNSAnnual Financial Report
30th Oct 201710:38 amRNS3rd Quarter Results
22nd Sep 201711:50 amRNSDirectorate Change
29th Aug 20177:00 amRNSHalf-year Report
30th Jun 201710:48 amRNSReport on Payments to Govts for 2015 and 2016
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.